Delivery Systems for RNA Interference Therapy: Current Technologies and Limitations

Author(s): Yi Wang*

Journal Name: Current Gene Therapy

Volume 20 , Issue 5 , 2020

Become EABM
Become Reviewer

Abstract:

In recent years, RNA interference technology has been extensively studied for its therapeutic potential against a wide variety of diseases. It aims to silence the expression of undesired genes associated with the target disease by the administration of RNA interference agents. However, these agents (nucleic acids) are unstable in the circulatory system and lack target specificity. Drug delivery systems are, therefore, crucial for the successful practice of the technique. A wide array of delivery systems has been developed to conquer these challenges, such as viral vectors, inorganic drug carriers, polymeric carriers and lipid-based carriers, with, however, significant limitations. In addition to the existing technologies, novel, innovative drug delivery systems, such as the configurable xenobot, are emerging at a rapid pace and have the potential to take the realm of biomedicine to the next level. This review summarizes technical difficulties in the development of drug delivery systems and current technologies developed for delivering RNAi agents with a discussion on their limitations.

Keywords: RNA interference, nucleic acid delivery, viral vector, exosome, albumin, liposome, xenobot.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 5
Year: 2020
Page: [356 - 372]
Pages: 17
DOI: 10.2174/1566523220666201005110726
Price: $95

Article Metrics

PDF: 8